Performa HargaHarga kembali 1 minggu1.54%
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)57.49
Harga Terendah (52 Minggu)45.38
Latar Belakang Perusahaan
Perusahaan biofarmasi yang mengembangkan terapi inovatif untuk penyakit autoimun dan kanker darah.
Summary
Valuation Information
Current PE Ratio (TTM)17.93
Forward PE Ratio61.35
Current Price to Book Value11.94
Current Price to Sales8.76
EV to Revenue9.78
EV to EBITDA56.11
PEG Ratio-0.25
Per Share
Current EPS (Annualized)2.74
Diluted EPS (TTM)2.74
Revenue Per Share5.61
Current Book Value Per Share4.11
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA136451000
Profit Margin0.552
Operating Margin0.0902
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
